TMO
Thermo Fisher Scientific Inc. · Healthcare · Medical - Diagnostics & Research
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 191 | +3 | 260.61M | $131.45B | +5 | −1 |
| Q1 2026 | 190 | +2 | 255.88M | $126.62B | +7 | −6 |
| Q4 2025 | 187 | +3 | 274.75M | $159.19B | +4 | — |
| Q3 2025 | 29 | -1 | 154.46M | $74.90B | +1 | −3 |
| Q2 2025 | 28 | +3 | 123.95M | $50.25B | +3 | — |
| Q1 2025 | 22 | -2 | 60.64M | $30.17B | — | −2 |
| Q4 2024 | 24 | +2 | 61.50M | $31.99B | +2 | — |
| Q3 2024 | 21 | -2 | 44.46M | $27.48B | — | −2 |
| Q2 2024 | 23 | — | 44.78M | $24.75B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 9.93M | — | $5.49B | 0.7% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 9.93M | — | $5.49B | 0.7% | n/c | 1 | SEC ↗ |
| 3 | Capital World Investors ✦ | 9.52M | — | $5.26B | 0.9% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 7.53M | — | $4.15B | 0.4% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasivo) | 7.53M | — | $4.15B | 0.4% | n/c | 1 | SEC ↗ |
| 6 | Norges Bank ✦ (pasivo) | 5.57M | — | $3.08B | 0.5% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 3.03M | — | $1.67B | 0.3% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 3.03M | — | $1.67B | 0.3% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 3.03M | — | $1.67B | 0.3% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 3.03M | — | $1.67B | 0.3% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 3.03M | — | $1.67B | 0.3% | n/c | 1 | SEC ↗ |
| 12 | Wellington Management ✦ | 3.03M | — | $1.67B | 0.3% | n/c | 1 | SEC ↗ |
| 13 | Wellington Management ✦ | 3.03M | — | $1.67B | 0.3% | n/c | 1 | SEC ↗ |
| 14 | Wellington Management ✦ | 3.03M | — | $1.67B | 0.3% | n/c | 1 | SEC ↗ |
| 15 | PRIMECAP Management ✦ | 2.67M | — | $1.47B | 1.1% | n/c | 1 | SEC ↗ |
| 16 | Fisher Asset Management ✦ | 2.57M | — | $1.42B | 0.6% | n/c | 1 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 982.69K | — | $543.43M | 0.5% | n/c | 1 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 982.69K | — | $543.43M | 0.5% | n/c | 1 | SEC ↗ |
| 19 | Baillie Gifford ✦ | 621.52K | — | $343.70M | 0.3% | n/c | 1 | SEC ↗ |
| 20 | Baillie Gifford ✦ | 621.52K | — | $343.70M | 0.3% | n/c | 1 | SEC ↗ |
| 21 | Baillie Gifford ✦ | 621.52K | — | $343.70M | 0.3% | n/c | 1 | SEC ↗ |
| 22 | Baillie Gifford ✦ | 621.52K | — | $343.70M | 0.3% | n/c | 1 | SEC ↗ |
| 23 | Millennium Management ✦ | 565.42K | — | $312.68M | 0.3% | n/c | 1 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 427.81K | — | $236.58M | 0.6% | n/c | 1 | SEC ↗ |
| 25 | Adage Capital Partners ✦ | 351.91K | — | $194.61M | 0.4% | n/c | 1 | SEC ↗ |
| 26 | Point72 Asset Management ✦ | 336.54K | — | $186.10M | 0.6% | n/c | 1 | SEC ↗ |
| 27 | Renaissance Technologies ✦ | 235.85K | — | $130.42M | 0.2% | n/c | 1 | SEC ↗ |
| 28 | D. E. Shaw & Co. ✦ | 201.26K | — | $111.30M | 0.2% | n/c | 1 | SEC ↗ |
| 29 | D. E. Shaw & Co. ✦ | 201.26K | — | $111.30M | 0.2% | n/c | 1 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 98.15K | — | $54.28M | 0.1% | n/c | 1 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 98.15K | — | $54.28M | 0.1% | n/c | 1 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 98.15K | — | $54.28M | 0.1% | n/c | 1 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 98.15K | — | $54.28M | 0.1% | n/c | 1 | SEC ↗ |
| 34 | Bridgewater Associates ✦ | 33.73K | — | $18.65M | 0.1% | n/c | 1 | SEC ↗ |
| 35 | Arrowstreet Capital ✦ | 29.95K | — | $16.56M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Markel Group ✦ | 29.40K | — | $16.26M | 0.2% | n/c | 1 | SEC ↗ |
| 37 | Dodge & Cox ✦ | 26.79K | — | $14.82M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Gotham Asset Management ✦ | 21.28K | — | $11.77M | 0.2% | n/c | 1 | SEC ↗ |
| 39 | GAMCO Investors ✦ | 4.29K | — | $2.37M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Marshall Wace ✦ | 700 | — | $387,100 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 24.30K acciones, $11,944 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer, Director · 321 acc. · $201,941
Officer, Director · 3.01K acc. · $1.89M
Officer, Director · 1.79K acc. · $1.12M
Officer, Director · 2.15K acc. · $1.35M
Officer, Director · 2.73K acc. · $1.71M
Officer, Director · 560 acc. · $354,446
Officer, Director · 80 acc. · $50,719
Officer, Director · 1.31K acc. · $824,745
Officer, Director · 2.60K acc. · $1.64M
Officer, Director · 1.25K acc. · $787,312
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología